Free shipping on all orders over $ 500

 About 1 result found for searched term "Garivulimab" (0.149 seconds)

Cat.No.  Name Target
M25083 Garivulimab PD-1/PD-L1
BGB-A333
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.